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In 2003, the US kidney allocation system was changed
to eliminate priority for HLA-B similarity. We report
outcomes from before and after this change using
data from the Scientific Registry of Transplant Recipi-
ents (SRTR). Analyses were based on 108 701 solitary
deceased donor kidney recipients during the 6 years
before and after the policy change. Racial/ethnic dis-
tributions of recipients in the two periods were com-
pared (chi-square); graft failures were analyzed using
Cox models. In the 6 years before and after the policy
change, the overall number of deceased donor trans-
plants rose 23%, with a larger increase for minorities
(40%) and a smaller increase for non-Hispanic whites
(whites) (8%). The increase in the proportion of trans-
plants for non-whites versus whites was highly sig-
nificant (p < 0.0001). Two-year graft survival improved
for all racial/ethnic groups after implementation of this
new policy. Findings confirmed prior SRTR predictions.
Following elimination of allocation priority for HLA-B
similarity, the deficit in transplantation rates among
minorities compared with that for whites was reduced
but not eliminated; furthermore, there was no adverse
effect on graft survival.
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Introduction
Several studies have documented that access to deceased-
donor renal transplantation in the United States is propor-
tionally greater for non-Hispanic whites (whites) than for
African Americans (1–10). Such disparity exists both for
placement on the waiting list and for receiving a kidney
transplant after wait-listing (7). Early kidney transplantation
experience established human leukocyte antigen (HLA)
match as a powerful factor in posttransplant graft survival.
However, dependence on HLA match grade to optimize
graft survival decreased with the introduction of the cal-
cineurin inhibitors cyclosporine and tacrolimus. The allo-
cation priority assigned for HLA similarity was gradually
reduced. Allocation priority for HLA-A similarity was elim-
inated in 1995. Following that change in allocation policy,
US allocation rules directed deceased donor kidneys first
to wait-listed candidates with no HLA A, B or DR mis-
matches with the donor and then according to a point
system that assigned points for HLA-B and DR similar-
ity, waiting time, pediatric age group, panel reactive anti-
body (PRA) level and previous living kidney donation (11).
Each point was equivalent to a year spent on the waiting
list.
The effect of HLA matching on graft survival is well es-
tablished (12, 13). However, among recipients with some
HLA mismatch at the A, B, or DR loci, the relative risk of
graft failure is only weakly related to the number of mis-
matches at the HLA-A or HLA-B loci but increases with the
number of mismatches at HLA-DR (14). Additional analyses
by the Scientific Registry of Transplant Recipients (SRTR)
predicted that the observed differences in transplanta-
tion rates by race/ethnicity would be reduced if points for
HLA-B similarity were eliminated (14).
Those analyses were the basis for a change in national
kidney allocation policy that was implemented on May 7,
2003. Before the policy change, points were assigned for
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combined phenotypic similarity at the HLA-B and HLA-DR
loci. Totals of zero, one and two mismatches for the com-
bined HLA-B and HLA-DR loci were advantaged by points
equivalent to 7, 5 and 2 years of waiting time, respectively.
By comparison, the new kidney transplant allocation algo-
rithm provides one or two points for one HLA-DR mismatch
or zero HLA-DR mismatch, respectively, and no longer as-
signs any points for HLA-B similarity. We evaluated the
effect of this change during the first 6 years following im-
plementation of the new allocation policy compared with
the 6 years before it. Comparisons were by race/ethnicity,
examining access to deceased donor transplantation
among wait-listed candidates and trends in graft survival.
Methods
Sources of data
We examined SRTR data for wait-listed deceased donor kidney transplant
candidates, recipients and donors in the United States. The SRTR sup-
plements data submitted to the Organ Procurement and Transplantation
Network (OPTN) with vital status and graft failure information from the So-
cial Security Death Master File and the Centers for Medicare & Medicaid
End-Stage Renal Disease (ESRD) database.
Race and ethnicity were those noted on the waiting list or transplant recipi-
ent registration forms. Following the OPTN data collection format, Hispanic
and non-Hispanic blacks were counted as African American. Hispanic and
non-Hispanic Asians were counted as Asians. Hispanic and non-Hispanic
Native Americans were counted as Native Americans. Non-Hispanic whites
(whites) and Hispanic whites (Hispanic/Latinos) were tabulated and evalu-
ated separately. Results for patients of other racial/ethnic groups are not
reported because of small numbers.
Analytic methods: outcomes before and after policy change
Analyses were based on 108 701 patients who received a solitary de-
ceased donor kidney transplant between May 7, 1997 and May 6, 2009.
Racial/ethnic distribution and HLA distribution of deceased donor kidney
transplant recipients were assessed during the 6 years before the alloca-
tion policy change and the 6 years following it. Significance was tested using
chi-square statistics. The distribution of patients on the kidney waiting list
or added to the kidney waiting list between May 7, 1997 and May 6, 2009
was computed.
Graft failure was analyzed 2 years after transplantation for those receiving
a deceased donor kidney before versus after the policy change using a Cox
model adjusted for donor sex, race, history of diabetes, cold ischemia time
and expanded criteria donor (ECD) status, and for recipient age, sex, PRA,
previous transplants, years of ESRD, previous transfusions and cause of
ESRD. Graft failure was defined as the earliest date among death, retrans-
plant of the same organ type, or initiation of maintenance dialysis. Pre-
versus postimplementation graft failure percentage changes were analyzed
overall and by racial/ethnic groups and HLA-B mismatch.
Human subjects statement
The Health Resources and Services Administration (HRSA), US Department
of Health and Human Services, has determined that this study satisfies the
criteria for the IRB exemption described in the ‘Public Benefit and Service
Program’ provisions of 45 CFR 46.101(b) (5) and HRSA Circular 03. This
study was approved by the HRSA SRTR project officer.
Results
The number and percentage of candidates on the kidney
waiting list on May 6, 1997 and added to the waiting list
in four 3-year intervals (May 7, 1997–May 6, 2000; May 7,
2000–May 6, 2003; May 7, 2003–May 6, 2006; and May 7,
2006–May 6, 2009) are shown by ethnicity group in Table 1.
More than half of the candidates on the kidney waiting list
on May 6, 1997 were non-white (53.5%). The percentage
of African American patients on the list on this date was
35% and the percentage of new African American pa-
tients added to the list in each 3-year interval was con-
siderably lower and remained relatively stable (28–29%).
Similarly, Table 2 shows the distribution of patients who
received a solitary deceased donor kidney transplant by
race/ethnicity in the same four 3-year intervals from 1997
to 2009. The effect of the policy change that eliminated al-
location priority for HLA-B similarity was evaluated among
the 108 701 patients who received a solitary deceased
donor kidney transplant between May 7, 1997 and May 6,
2009. There were 48 776 deceased donor transplants per-
formed in the 6 years before the policy change and 59 925
transplants performed in the 6 years after policy imple-
mentation (a 23% increase overall). When comparing the
6 years before the policy change with the 6 years after,
the number of transplants performed increased for each
of the examined ethnic/racial groupings. However, each
minority group exhibited a greater increase in the num-
ber of transplants than the average of 23%, whereas,
whites exhibited a significantly smaller increase (8%; p
< 0.0001). The percentage of whites receiving a deceased
donor transplant declined after the policy change (54% to
47%) and most recently mirrors the percentage of whites
newly added to waiting list (47%).
Prior to the policy change, the number of non-white trans-
plants had been increasing and the number of white trans-
plants declining (Table 2). To exclude the possibility that
the change in transplant rates observed after the policy
change might reflect only an early bolus effect rather than
a longer-term consequence, we analyzed the numbers of
white versus non-white transplant recipients by 6-month
intervals over the 12 years of the study period (Figure 1).
In the 6 years before the policy change, whites had
more transplants than non-whites in all 12 of the 6-month
intervals. This predominance reversed immediately af-
ter the policy change, such that in the 6 years follow-
ing the new rule, non-whites received more transplants
than whites in every 6-month interval (12 of 12). Over-
all, the increase in the proportion of transplants for non-
whites from pre- to postpolicy change was highly signifi-
cant (p < 0.0001).
The percentage of zero mismatch kidney transplants de-
creased from almost 15% before the policy change to
13–14% after it (Table 2). Among mismatched recipients,
however, there were substantial changes following the pol-
icy revision. As shown in the first two bars in Figure 2,




































































































































































































































































































































































































































































during the two 3-year periods before the policy change,
44–52% of the HLA mismatched transplant recipients re-
ceived no points for combined HLA B-DR match, while
about 17–21% received 5 points and 2% 7 points for HLA
B-DR similarity. After the policy change, only about 38–
40% of the mismatched transplant recipients received no
points for HLA DR match, while about 49–50% received
1 point for HLA DR match and approximately 11–12% re-
ceived 2 points for HLA DR match. As expected, match-
ing for HLA-B declined when points for HLA-B match were
removed: the percentage of two HLA-B mismatched trans-
plant recipients increased from 46% (May 1997 to May
2000) to 72% (May 2006 to May 2009). In contrast, the
percentage of two HLA-DR mismatches increased in those
same intervals from 26% to 40%.
Overall, the adjusted relative graft survival percentages in
the cohorts assessed 2 years after transplantation were
higher after the policy change than before it (p < 0.05)
(Table 3). From the 1997–2000 cohort to the 2006–2009 co-
hort, 2-year graft survival increased from 84.1% to 87.4%
for white recipients and from 80.2% to 84.7% for African
Americans recipients. Graft survival for Hispanic/Latinos,
Asians and Native Americans was not statistically different
among the four cohorts (May 1997 to May 2000, May 2000
to May 2003, May 2003 to May 2006 and May 2006 to May
2009), although it was higher among postpolicy transplant
recipients than prepolicy recipients. Two-year graft survival
increased, from 87.6% to 90.2% for zero mismatch re-
cipients and from 83.0% to 86.7% for nonzero mismatch
recipients from the 1997–2000 cohort to the 2006–2009
cohort. Substantial improvements were observed in the
outcomes of both HLA-B mismatched and HLA-B nonmis-
matched transplants.
A subgroup analysis done separately for standard criteria
donor (SCD) and ECD transplants showed that the trends
in the percentage distribution by race/ethnicity displayed
in Figure 1 were very similar for SCD kidney transplants;
however, for ECD transplants, the percentage of organs
received by nonwhites changed little during the last three
time periods.
For illustration purposes, Figure 3 presents the active wait-
ing list (N = 54 265) on the day before the policy change
(May 6, 2003), by time since wait-listing.
Discussion
The consequences of reducing allocation points for HLA
similarity from two, five and seven to only one and two can
be predicted from an understanding of the point-prevalent
snapshot of time on the waiting list by years. Figure 3 il-
lustrates that receiving seven or five points for zero or for
one combined HLA-B and DR mismatch would allow can-
didates to jump ahead of almost the entire national waiting
list. With similar waiting times, candidates given five and
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Table 2: Deceased donor kidney transplants before and after policy change eliminating points for HLA-B similarity by race/ethnicity and
zero mismatch, 1997–2009
Deceased Donor Transplants Before Policy









Race/Ethnicity N % N % N % N %
Non-White 10 592 44.2 11 936 48.1 14 677 52.0 16 952 53.5
African American 6 581 27.5 7 329 29.5 8 543 30.2 9 910 31.3
Hispanic/Latino 2 574 10.8 3 101 12.5 3 962 14.0 4 738 15.0
Asian 1 194 5.0 1 244 5.0 1 760 6.2 1 887 6.0
Native American 240 1.0 250 1.0 330 1.2 327 1.0
Multiracial/Other 3 0.0 12 0.0 82 0.3 90 0.3
White 13 351 55.8 12 897 51.9 13 569 48.0 14 727 46.5
Zero MM 3 760 14.7 3 660 14.7 4 056 14.4 4 107 13.0
All 23 943 100 24 833 100 28 246 100 31 679 100
seven points would receive organs before high-PRA can-
didates (who received a four-point advantage) (11). There-
fore, reducing the allocation priority for HLA-DR similarity
to a maximum of two points resulted in greater access to
transplantation for children and high-PRA candidates.
The smaller percentage of zero HLA-DR mismatches is
likely a reflection of the decrease in the number of points
potentially provided for HLA-DR similarity. This resulted in a
relative shift in overall allocation priority away from HLA-DR
matching and toward waiting time.
The observed shift in organs from the white candidate
pool to the minority pool persists even after the first
2 years of the new policy; it is consistent with and vali-
dates the results of the preimplementation SRTR statis-
tical models (14). Under the previous allocation system,
candidates with disadvantaged antigens had accumulated
years on the waiting list. Therefore a bolus effect after
the policy change might have been expected to give mi-
nority candidates a transient waiting time advantage; it
is possible the rapidity of change in allocation that was
observed within the first 6 months of the new policy re-
flects such a bolus. However, analysis of each of the twelve
6-month periods following the policy change indicates that
the number of deceased donor kidney transplants received
by minority groups remained higher than that observed
for white recipients. This suggests an apparent steady-
state beyond that observed during the first 3 years fol-
lowing policy change. It is notable that while non-white
candidates in aggregate are still not transplanted at rates
proportionate to their representation on the waiting list,
this deficit is reduced compared with that seen at the
beginning of the study period. Furthermore, transplant
Figure 1: Number of transplants by
race and 6-month period, May 7,
1997–May 6, 2009. The pre-policy pe-
riod was from May 7, 1997 to May 6,
2003. The postpolicy period was from
May 7, 2003 to May 6, 2009.
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Figure 2: Distribution of nonzero
mismatch kidney transplants by HLA
B-DR points and by HLA B and
HLA DR mismatch before and after
the policy change∗, 1997–2009. ∗Pre-
Policy: 5/7/97-5/6/00 (N = 20,028) &
5/7/03-5/6/06 (N = 21,049); Post-Policy:
5/7/00-5/6/03 (N=23,948) & 5/7/06-
5/6/09 (N = 27,318). ∗∗Each point pro-
vides allocation policy equal to one year
of waiting time credit
percentages for each individual race/ethnic group closely
approximate the frequency at which they are added to the
waiting list.
The finding of lower graft failure rates in all racial/ethnic
groups during the first 2 years after the policy change sup-
ports predictions from prior SRTR statistical models. These
models indicated that no substantial graft survival effect by
the level of HLA-B matching would be seen among recip-
ients of mismatched deceased donor kidney transplants
(14). There was a gradual improvement in deceased donor
kidney graft survival over the recent decade (15). There-
fore, the observed overall reduction in graft failure during
the second 2-year period may be explained, in part, by this
time trend. Although the general improvement in graft sur-
vival might have offset any potentially adverse effect of
the policy change on graft outcomes, no decline in 2-year
graft survival was observed following the implementation
of this policy.
There is no evidence that the overall increase in minority
transplantation has significantly affected graft survival, as
the overall graft survival in the two eras after the policy
change was 85.0% and 87.2%, respectively. These values
are very close to the 85.1% and 87.2% observed, respec-
tively, in the same time intervals in the white population.
This suggests that the system-wide effect on 2-year al-
lograft survival is minimal. This policy change, however,
does not address the challenge of finding more organs to
transplant. Other effects of this policy change, such as eco-
nomic and quality of life benefit, have been suggested (16)
but are beyond the scope of this study.
Given the prior large difference in transplantation rates af-
ter wait-listing observed for African Americans or Native
Americans compared with whites (1–10), these new
findings indicate a substantial reduction in the large
advantage that wait-listed whites had with the prior policy.
The racial composition of the additions to the waiting list
1716 American Journal of Transplantation 2011; 11: 1712–1718
HLA-B Matching and Kidney Allocation
Table 3: Two-year adjusted1 graft survival before and after policy change eliminating points for HLA-B similarity by race and by HLA
mismatch, 1997–2009
2-Year Graft Survival1 (95% CI)
Pre-Policy Transplants Post-Policy Transplants
Group May 7, 1997–May 6, 2000 May 7, 2000–May 6, 2003 May 7, 2003–May 6, 2006 May 7, 2006–May 6, 2009
White 84.1 (83.5, 84.7) 84.3 (83.7, 84.9) 85.1 (84.6, 85.7) 87.4 (86.8, 88.0)
Non-White2 83.1 (82.4, 83.8) 83.4 (82.8, 84.0) 84.7 (84.2, 85.3) 86.9 (86.4, 87.5)
African American 80.2 (79.3, 81.2) 80.6 (79.7, 81.5) 82.3 (81.5, 83.1) 84.7 (84.0, 85.5)
Hispanic/Latino 88.2 (86.9, 89.4) 87.9 (86.7, 89.0) 87.6 (86.6, 88.6) 89.7 (88.8, 90.7)
Asian 87.0 (85.1, 88.9) 87.4 (85.6, 89.2) 88.4 (87.0, 89.9) 90.4 (89.0, 92.4)
Native American 82.7 (78.3, 87.3) 83.8 (79.6, 88.2) 90.2 (87.2, 93.3) 87.1 (83.0, 91.3)
Zero MM 87.6 (86.5, 88.7) 87.8 (86.7, 88.8) 88.8 (87.9, 89.8) 90.2 (89.2, 91.2)
Non-Zero MM2 83.0 (82.5, 83.5) 83.2 (82.8, 83.7) 84.3 (83.9, 84.8) 86.7 (86.3, 87.1)
0 B MM 86.2 (84.8, 87.7) 84.8 (83.2, 86.5) 86.9 (84.3, 89.7) 88.6 (85.9, 91.5)
1 B MM 83.6 (82.9, 84.4) 84.8 (84.1, 85.6) 84.5 (83.6, 85.3) 86.7 (85.9, 87.6)
2 BMM 81.8 (81.0, 82.6) 81.9 (81.2, 82.6) 84.3 (83.8, 84.8) 86.7 (86.2, 87.2)
All 83.6 (83.2, 84.1) 83.9 (83.4, 84.3) 85.0 (84.5, 85.4) 87.2 (86.8, 87.6)
1Adjusted 2-year graft survival following transplantation of a deceased-donor solitary kidney. Adjusted for donor sex, race, history of
diabetes, cold ischemia time, ECD and recipient age, sex, PRA, previous transplants, years of ESRD, previous transfusions and cause of
ESRD.
2Multiracial/Other race and unknown B mismatch not shown due to small sample size.









Years on the Waitlist


















Figure 3: Number of can-
didates on the kidney
waiting list by years on
the waiting list based on
a cross-section of all wait-
listed patients on May 6,
2003. Arrows indicate al-
location policy of awarding
points for HLA match (each
point is equivalent to 1 year
of waiting time).
has gradually increased for Hispanic/Latino and Asian can-
didates over the course of the 12-year time period (Table 1).
This suggests that barriers to getting wait-listed have also
improved, but, likely, only partially.
In summary, the current policy, which offers no allocation
priority for HLA-B similarity and gives only one and two
points for matches at HLA-DR, has improved access to
transplantation for all minority groups and has not been
associated with a decrease in 2-year graft survival during
the first 6 years following the policy change. This new pol-
icy improved equity in access to deceased donor trans-
plantation among wait-listed candidates without impairing
posttransplant outcomes.
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